BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 28634084)

  • 1. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the delivery of therapies to melanoma brain metastases.
    Gampa G; Vaidhyanathan S; Resman BW; Parrish KE; Markovic SN; Sarkaria JN; Elmquist WF
    Curr Pharmacol Rep; 2016 Dec; 2(6):309-325. PubMed ID: 28546917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
    Murrell J; Board R
    Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
    Parrish KE; Sarkaria JN; Elmquist WF
    Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
    Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
    Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma brain metastases: Biological basis and novel therapeutic strategies.
    Phadke M; Ozgun A; Eroglu Z; Smalley KSM
    Exp Dermatol; 2022 Jan; 31(1):31-42. PubMed ID: 33455008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
    Gibney GT; Gauthier G; Ayas C; Galebach P; Wu EQ; Abhyankar S; Reyes C; Guérin A; Yim YM
    Cancer Med; 2015 Aug; 4(8):1205-13. PubMed ID: 25991583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the systemic treatment of melanoma brain metastases.
    Glitza Oliva IC; Schvartsman G; Tawbi H
    Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of systemic therapy in melanoma brain metastases: a narrative review.
    Saleem K; Davar D
    Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
    Schvartsman G; Ma J; Bassett RL; Haydu LE; Amaria RN; Hwu P; Wong MK; Hwu WJ; Diab A; Patel SP; Davies MA; Hamerschlak N; Tawbi HA; Glitza Oliva IC
    Cancer; 2019 Dec; 125(23):4193-4202. PubMed ID: 31398264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases.
    Gampa G; Kim M; Cook-Rostie N; Laramy JK; Sarkaria JN; Paradiso L; DePalatis L; Elmquist WF
    Drug Metab Dispos; 2018 May; 46(5):658-666. PubMed ID: 29437873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
    Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
    Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of systemic therapies in the management of melanoma brain metastases.
    Lyle M; Long GV
    Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases.
    Gampa G; Kim M; Mohammad AS; Parrish KE; Mladek AC; Sarkaria JN; Elmquist WF
    J Pharmacol Exp Ther; 2019 Mar; 368(3):446-461. PubMed ID: 30622172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Era in the Management of Melanoma Brain Metastases.
    Tawbi HA; Boutros C; Kok D; Robert C; McArthur G
    Am Soc Clin Oncol Educ Book; 2018 May; 38():741-750. PubMed ID: 30231345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
    Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
    Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapies for melanoma brain metastases: which drug for whom and when?
    Ramanujam S; Schadendorf D; Long GV
    Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
    Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
    Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
    Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
    Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights into melanoma brain metastases.
    Westphal D; Glitza Oliva IC; Niessner H
    Cancer; 2017 Jun; 123(S11):2163-2175. PubMed ID: 28543697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.